Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer: a Prospective Exploratory Trial (POHIM_RT Trial)

NCT03239626 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03239626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03239626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer: a Prospective Exploratory Trial (POHIM_RT Trial)
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 31, 2017
Completion date
April 28, 2025
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervix cancer, hypofractionated dose, radiotherapy, adjuvant, radiotherapy, intensity-modulated